Amarin Corporation plc

4.76-0.2000-4.03%Vol 11.07M1Y Perf -31.04%
Jun 21st, 2021 15:19 DELAYED
BID4.76 ASK4.77
Open4.95 Previous Close4.96
Pre-Market4.92 After-Market-
 -0.04 -0.81%  - -
Target Price
10.38 
Analyst Rating
Moderate Buy 1.60
Potential %
116.70 
Finscreener Ranking
★★★★★     67.82
Insiders Trans % 3/6/12 mo.
100/-33/-20 
Value Ranking
★★★★★     63.76
Insiders Value % 3/6/12 mo.
100/-97/-92 
Growth Ranking
★★★★+     67.39
Insiders Shares Cnt. % 3/6/12 mo.
100/-95/-90 
Income Ranking
 —    -
Market Cap1.88B 
Earnings Rating
Strong Buy
Price Range Ratio 52W %
23.77 
Earnings Date
3rd Aug 2021

Today's Price Range

4.384.96

52W Range

3.369.25

5 Year PE Ratio Range

-48.00-4.40

Summary:

Neutral

Technical Indicators: Buy
Moving Averages: Neutral
Performance
1 Week
0.20%
1 Month
10.22%
3 Months
-22.98%
6 Months
-0.40%
1 Year
-31.04%
3 Years
54.52%
5 Years
141.95%
10 Years
-63.77%

TickerPriceChg.Chg.%
AMRN4.76-0.2000-4.03
AAPL132.061.60001.23
GOOG2 533.1621.81000.87
MSFT262.062.63001.01
XOM62.622.22003.68
WFC43.171.42003.40
JNJ164.002.02001.25
FB332.052.39000.72
GE13.120.34002.66
JPM149.962.04001.38
Financial StrengthValueIndustryS&P 500US Markets
2.00
2.90
0.01
0.01
4.20
Leverage Ratio 1.60
ProfitabilityValueIndustryS&P 500US Markets
79.20
1.00
1.40
-29.60
0.32
RevenueValueIndustryS&P 500US Markets
601.24M
1.52
37.61
43.15
Earnings HistoryEstimateReportedSurprise %
Q01 2021-0.050.00100.00
Q04 2020-0.010.01200.00
Q03 20200.01-0.02-300.00
Q02 2020-0.080.01112.50
Q01 2020-0.06-0.060.00
Q04 2019-0.030.02166.67
Q03 2019-0.04-0.0175.00
Q02 2019-0.02-0.0150.00
Earnings Per EndEstimateRevision %Trend
6/2021 QR-0.030.00-
9/2021 QR-0.04-100.00Negative
12/2021 FY-0.127.69Positive
12/2022 FY-0.02-125.00Negative
Next Report Date3rd Aug 2021
Estimated EPS Next Report-0.03
Estimates Count6
EPS Growth Next 5 Years %-
Volume Overview
Volume11.07M
Shares Outstanding394.77M
Trades Count32.86K
Dollar Volume39.34M
Avg. Volume5.66M
Avg. Weekly Volume4.97M
Avg. Monthly Volume3.15M
Avg. Quarterly Volume4.32M

Amarin Corporation plc (NASDAQ: AMRN) stock closed at 4.96 per share at the end of the most recent trading day (a 0.61% change compared to the prior day closing price) with a volume of 7.89M shares and market capitalization of 1.88B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 1000 people. Amarin Corporation plc CEO is John F. Thero.

The one-year performance of Amarin Corporation plc stock is -31.04%, while year-to-date (YTD) performance is 1.43%. AMRN stock has a five-year performance of 141.95%. Its 52-week range is between 3.36 and 9.25, which gives AMRN stock a 52-week price range ratio of 23.77%

Amarin Corporation plc currently has a PE ratio of -1 201.50, a price-to-book (PB) ratio of 3.08, a price-to-sale (PS) ratio of 3.25, a price to cashflow ratio of 329.80, a PEG ratio of 2.32, a ROA of 0.09%, a ROC of 0.00% and a ROE of 0.15%. The company’s profit margin is 0.32%, its EBITDA margin is 1.40%, and its revenue ttm is $601.24 Million , which makes it $1.52 revenue per share.

Of the last four earnings reports from Amarin Corporation plc, there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.03 for the next earnings report. Amarin Corporation plc’s next earnings report date is 03rd Aug 2021.

The consensus rating of Wall Street analysts for Amarin Corporation plc is Moderate Buy (1.6), with a target price of $10.38, which is +116.70% compared to the current price. The earnings rating for Amarin Corporation plc stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Amarin Corporation plc has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Amarin Corporation plc has a Neutral technical analysis rating based on Technical Indicators (ADX : 21.14, ATR14 : 0.19, CCI20 : 74.21, Chaikin Money Flow : 0.16, MACD : 0.03, Money Flow Index : 51.72, ROC : 8.06, RSI : 57.01, STOCH (14,3) : 84.38, STOCH RSI : 0.54, UO : 64.96, Williams %R : -15.63), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Amarin Corporation plc in the last 12-months were: Aaron D. Berg (Option Excercise at a value of $0), David M. Stack (Buy at a value of $311 500), John F. Thero (Option Excercise at a value of $2 550 000), John F. Thero (Sold 567 405 shares of value $2 317 158 ), Joseph S. Zakrzewski (Option Excercise at a value of $680 000), Joseph T. Kennedy (Option Excercise at a value of $0), Michael Wayne Kalb (Option Excercise at a value of $0), Steven B. Ketchum (Option Excercise at a value of $1 250 448), Steven B. Ketchum (Sold 639 357 shares of value $5 132 264 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (70.00 %)
8 (66.67 %)
7 (70.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (30.00 %)
4 (33.33 %)
2 (20.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
1 (10.00 %)
Summary RatingModerate Buy
1.60
Moderate Buy
1.67
Moderate Buy
1.80

Amarin Corporation plc

Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular health. Its lead product includes Vascepa.

CEO: John F. Thero

Telephone: +353 16699020

Address: 77 Sir John Rogerson's Quay, Dublin D02 VK60, , IE

Number of employees: 1 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

67%33%

Bearish Bullish

55%45%

Bearish Bullish

52%48%

News

Stocktwits